• Michael Bryant
    "Affymax (AFFY) Rises on Deal With Fresenius for Kidney Therapy." $700 million? AFFY is only $596 million. http://bloom.bg/PVD3Me
    7/13/12
    Reply (1)
    • bigfoot: On a sales multiple basis, AFFY could easily be a $30 stock. That makes it a great acquisition target, too.l
      7/13/12